Oryzon Genomics SA (ORY.MC) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Spain · ISIN ES0167733015
Oryzon Genomics SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 7.36 m EUR | 0.00 EUR |
| Gross profit | 7.06 m EUR | -133,906.00 EUR |
| Operating income | -4.42 m EUR | -6.42 m EUR |
| EBIT | -4.58 m EUR | -6.42 m EUR |
| Net income | -3.67 m EUR | -2.61 m EUR |
| Diluted EPS – continuing operations | -0.06 EUR | -0.03 EUR |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Oryzon Genomics SA
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
More stocks
- FIRST OTTAWA BANCSHARES, INC. (FOTB)
- COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI)
- Sheng Yu Steel Co Ltd (2029.TW)
- Taokaenoi Food & Marketing Public Company Limited (TKN.BK)
- Shanghai Jin Jiang International Industrial Investment Co Ltd B (900914.SS)
- Pulmuone Holdi (017810.KS)
- KALTURA INC (KLTR)
- Ceragon Networks Ltd (CRNT)
- Arlandastad Group AB (AGROUP.ST)
- MESABI TRUST (MSB)
- Zona Franca de Iquique S.A (ZOFRI.SN)
- Shanghai Phoenix Enterprise Group Co Ltd B (900916.SS)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.